Topical tacrolimus and pimecrolimus: Future directions

Seminars in Cutaneous Medicine and Surgery

Volumn 20, Issue 4, 2001, Pages 268-274

  Ling, M R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; PIMECROLIMUS; TACROLIMUS;

ALOPECIA; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; HUMAN; LICHEN PLANUS; OINTMENT; PSORIASIS; PYODERMA GANGRENOSUM; SEBORRHEIC DERMATITIS; SKIN ALLERGY; SKIN INFLAMMATION;

EID: 0035208349     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1053/sder.2001.29060     Document Type: Article

References (33)

1. Tacrolimus 0.1% ointment in the treatment of eyelid dermatitis
2. The role of Pityrosporum ovale in seborrheic dermatitis
3. Tacrolimus has antifungal activities against Malassezia furfur isolated from healthy adults and patients with atopic dermatitis
4. Topical FK506: Suppression of allergic and irritant contact dermatitis in the guinea pig
5. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs
6. Immunosuppressive macrolides of the type FK506: A novel class of topical agents for treatment of skin diseases?
7. Inhibition of contact allergy reactions by topical FK506
8. Significant absorption of topical tacrolimus in 3 patients with Netherton Syndrome
9. For the Tacrolimus Ointment Study Group: A long-term noncomparative trial to evaluate the safety of topically applied tacrolimus as treatment of atopic dermatitis in pediatric patients
10. Tacrolimus (FK506): A new therapeutic agent for severe recalcitrant psoriasis
11. European FK506 Multicentre Psoriasis Study Group: Systemic tacrolimus is effective for the treatment of psoriasis in a double-blind, placebo-controlled study
12. Comparative evaluation of tacrolimus (FK506) and cyclosporin A as immunosuppressive agents
13. The enigma of cyclosporin A treatment for psoriasis: Systemic efficacy versus topical nonresponsiveness. A review
14. Topical tacrolimus is not effective in chronic plaque psoriasis: A pilot study
15. Tacrolimus ointment improves psoriasis in a microplaque assay
16. Oral SDZ ASM 981: Clinical safety, tolerability, and efficacy in patients with moderate to severe chronic plaque psoriasis
17. The novel ascomycin derivative SDZ ASM 981 is effective for psoriasis when used topically under occlusion
18. An insider's guide to new psoriasis treatments
19. Topical FK506: A potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model
20. Stimulation of hair growth by topical application of FK 506, a potent immunosuppressive agent
21. Topical tacrolimus, Treatment failure in a patient with alopecia areata
22. Erosive mucosal lichen planus: Response to topical treatment with tacrolimus
23. Successful treatment of erosive lichen planus with topical tacrolimus
24. Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease: A case series of 18 patients
25. Topical tacrolimus maybe useful on skin manifestations of acute and chronic graft-versus-host disease (GVHD) after bone marrow transplantation (BMT)
26. Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus
27. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum
28. Topical tacrolimus for pyoderma gangrenosum
29. Topical tacrolimus for pyoderma gangrenosum
30. Topical tacrolimus for recalcitrant leg ulcer in rheumatoid arthritis
31. Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease
32. Tacrolimus ointment for the treatment of steroid-induced rosacea: A preliminary report
33. Eosinophilic pustular folliculitis